Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Unituxin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of this type of cancer… Expand
  • figure 1
  • figure 2
Review
2018
Review
2018
Neuroblastoma is the most common pediatric solid tumor of neural crest origin. The current treatment options for neuroblastoma… Expand
  • table 1
  • table 2
  • table 3
Review
2016
Review
2016
  • J. Mora
  • Expert review of clinical pharmacology
  • 2016
  • Corpus ID: 30954364
ABSTRACT Neuroblastoma (NB) is the most common extra cranial solid tumor of childhood, with 60% of patients presenting with high… Expand
2016
2016
  • The Medical letter on drugs and therapeutics
  • 2016
  • Corpus ID: 39711793
 
2016
2016
Background: Gangliosides such as GD2, GD3 and GM2 are promising targets for antibody-mediated cancer therapy since they are… Expand
Review
2016
Review
2016
  • J. Bernstein
  • Pediatric blood & cancer
  • 2016
  • Corpus ID: 206339758
A the parent of a child who has been undergoing treatment for high-risk neuroblastoma for most of his 5 years of life, I was… Expand
2015
2015
The US Food and Drug Administration has approved dinutuximab (Unituxin) for the treatment of high-risk neuroblastoma in pediatric… Expand